Secondary prevention of heart disease and stroke: work to do

被引：1
作者：
Heagerty, Anthony M. [1 ]
机构：
[1] Univ Manchester, Cardiovasc Res Grp, Manchester M13 9NT, Lancs, England
来源：
LANCET | 2011年 / 378卷 / 9798期
关键词：
GUIDELINES; MANAGEMENT;
D O I：
10.1016/S0140-6736(11)61302-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1200 / 1202
页数：3
相关论文
共 50 条
  • [21] Secondary Prevention of Ischemic Stroke in Urban China
    Wei, Jade W.
    Wang, Ji-Guang
    Huang, Yining
    Liu, Ming
    Wu, Yangfeng
    Wong, Lawrence K. S.
    Cheng, Yan
    Xu, En
    Yang, Qidong
    Arima, Hisatomi
    Heeley, Emma L.
    Anderson, Craig S.
    STROKE, 2010, 41 (05) : 967 - 974
  • [22] Cilostazol for secondary stroke prevention: systematic review and meta-analysis
    Tan, Choon Han
    Wu, Andrew G. R.
    Sia, Ching-Hui
    Leow, Aloysius S. T.
    Chan, Bernard P. L.
    Sharma, Vijay Kumar
    Yeo, Leonard L. L.
    Tan, Benjamin Y. Q.
    STROKE AND VASCULAR NEUROLOGY, 2021, 6 (03) : 410 - 423
  • [23] Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?
    van Peet, Petra G.
    Gussekloo, Jacobijn
    den Elzen, Wendy P. J.
    Blom, Jeanet W.
    de Waal, Margot W. M.
    de Ruijter, Wouter
    SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2015, 33 (04) : 260 - 268
  • [24] Use of cardiovascular polypills for the secondary prevention of cerebrovascular disease
    Masjuan, J.
    Gallego, J.
    Aguilera, J. M.
    Arenillas, J. F.
    Castellanos, M.
    Diaz, F.
    Portilla, J. C.
    Purroy, F.
    NEUROLOGIA, 2021, 36 (01): : 1 - 8
  • [25] The Enhancing Secondary Prevention in Coronary Artery Disease trial
    McAlister, Finlay A.
    Fradette, Miriam
    Majumdar, Sumit R.
    Williams, Randall
    Graham, Michelle
    McMeekin, James
    Ghali, William A.
    Tsuyuki, Ross T.
    Knudtson, Merril L.
    Grimshaw, Jeremy
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2009, 181 (12) : 897 - 904
  • [26] Determinants of appropriate lipid management in patients with ischaemic heart disease. Cracovian Program for Secondary Prevention of Ischaemic Heart Disease
    Kawecka-Jaszcz, K
    Jankowski, P
    Pajak, A
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2003, 91 (01) : 15 - 23
  • [27] Hemoglobin S target of <50% as compared to 30% in chronic red cell exchange for secondary stroke prevention in sickle cell disease
    Choi, Jihee
    Markantonis, John Emmanuel
    De Simone, Nicole
    Nero, Alecia
    Kim, Jaehyup
    Sarode, Ravi
    JOURNAL OF CLINICAL APHERESIS, 2023, 38 (06) : 677 - 684
  • [28] Secondary prevention of coronary heart disease. A survey in an Italian primary care practice
    Modesti, A.
    Del Papa, C.
    Modesti, L.
    Bartaloni, R.
    Galloni, V.
    Dell'Omo, G.
    Pedrinelli, R.
    MINERVA CARDIOANGIOLOGICA, 2010, 58 (02): : 167 - 173
  • [29] Long-Term Effects of Secondary Prevention on Cognitive Function in Stroke Patients
    Douiri, Abdel
    McKevitt, Christopher
    Emmett, Eva S.
    Rudd, Anthony G.
    Wolfe, Charles D. A.
    CIRCULATION, 2013, 128 (12) : 1341 - 1348
  • [30] Disparities between prescribing of secondary prevention therapies for stroke and coronary artery disease in general practice
    Heeley, Emma
    Anderson, Craig
    Patel, Anushka
    Cass, Alan
    Peiris, David
    Weekes, Andrew
    Chalmers, John
    INTERNATIONAL JOURNAL OF STROKE, 2012, 7 (08) : 649 - 654
12345